Wassilew Nasstasja, Ciaffi Laura, Calmy Alexandra
HIV/AIDS Unit, Department of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland.
BMJ Case Rep. 2015 May 14;2015:bcr2014208241. doi: 10.1136/bcr-2014-208241.
Mycobacterium genavense is a rare pathogen affecting severely immunosuppressed patients. We report the case of persistent relapsing M. genavense infection in a 48-year-old African man with a positive diagnosis of HIV infection. Despite being under effective antiretroviral therapy with partial immune reconstitution, he developed irreversible long-term abdominal complications, possibly due to persistent M. genavense infection and sustained inflammation. Case management consists of individual risk assessment, close follow-up and personalised treatment strategies concerning the duration of antimycobacterial therapy and early application of steroids. Patients with profound immunosuppression, a high viral load at HIV diagnosis and a high burden of M. genavense, appear to be at higher risk. The pathogenicity of this complication is not well known and its optimal management has still to be determined.
日内瓦分枝杆菌是一种罕见的病原体,可感染严重免疫抑制的患者。我们报告了一例48岁非洲男性持续性复发性日内瓦分枝杆菌感染病例,该患者HIV感染诊断呈阳性。尽管接受了有效的抗逆转录病毒治疗且部分免疫功能得到重建,但他仍出现了不可逆的长期腹部并发症,可能是由于日内瓦分枝杆菌持续感染和持续炎症所致。病例管理包括个体风险评估、密切随访以及关于抗分枝杆菌治疗持续时间和早期应用类固醇的个性化治疗策略。免疫抑制严重、HIV诊断时病毒载量高以及日内瓦分枝杆菌负荷高的患者似乎风险更高。这种并发症的致病性尚不清楚,其最佳管理方案仍有待确定。